ArticleRespirology case reports2024

Feasibility of continued treatment with dupilumab in patients with type 2 inflammatory disease who developed eosinophilic pneumonia: 3 case reports.

Masamitsu Hamakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.